Vagus Nerve Stimulation Market to Showcase Impressive Growth, Fueled by Rising Demand for Minimally Invasive Procedures | Reveals by FMI

Currently, implantable vagus nerve stimulator accounts for a whopping share of the revenue of the vagus nerve stimulator market. As indicated by a newly published intelligence study by Future Market Insights, the global vagus nerve stimulator market is likely to demonstrate robust year-on-year revenue growth of more than 9% in 2019.

The Vagus Nerve Stimulator Market is poised for substantial growth between 2018 and 2026, driven by its diverse applications across various medical fields. This market report explores the market dynamics based on different applications, including Pain Management, Epileptic Seizures, Obesity Management, Depression, and Anxiety.

Claim your complimentary report with captivating visuals.
https://www.futuremarketinsights.com/reports/sample/rep-gb-7759

Vagus Nerve Stimulation Market to Showcase Impressive Growth, Fueled by Rising Demand for Minimally Invasive ProceduresThe Vagus Nerve Stimulator Market, spanning applications like pain management, epilepsy control, obesity treatment, and mental health, shows promising growth from 2018 to 2026. Epilepsy management remains a dominant segment, while innovations and regional variations play key roles. North America and Europe lead in adoption, with Asia-Pacific emerging as a potential growth market. Continuous technological advancements and strategic collaborations fuel market expansion.

• Of the total global population inflicted by neurological disorders, approximately 50% suffer from an epileptic disorder, research and surveys say.
• Vagus nerve stimulation is witnessing a rapidly expanding applicability beyond epilepsy, in the recent past.
• Research uncovers the potential efficiency of vagus nerve stimulation in the obesity management of depression patients.
• The positive outcome of vagus nerve stimulation in treatment-resistant depression and epilepsy surgery indicate promising opportunities approaching in the near future.

Europe Steals the Limelight, Crossing US$ 100 Million Revenue in 2019

North America currently holds a massive revenue share in the vagus nerve stimulator market, and FMi projects continued dominance of this region over other regional markets in comping years. However, the report forecasts emergence of Europe and Asia Pacific (excluding Japan) as highly attractive territories for key market players in the near future. Europe will reportedly cross the US$ 100 million mark in 2019, reflecting the most lucrative opportunities for vagus nerve stimulator manufacturers.

“At present, Europe and APEJ hold a collective revenue share of over 40% in market, of which the former is gradually moving towards extending its individual market value share up to 1/4^th of the global revenue,” explains a senior research analyst at FMI. Adding further, the analyst says, “Favorable regulatory and reimbursement scenario across Europe and relatively easy availability of VNS systems are most prominently driving the growth of vagus nerve stimulator market in Europe. VNS sales in Europe will also benefit from the strong presence of leading industry manufacturers in the region”.

Taxonomical Insights – By Type, Application, and End User

• By the type of vagus nerve stimulator, implantable stimulator continues to bring in the most of the revenue to market.
• Epileptic seizures secure the spot of the most sought after application type in vagus nerve stimulator landscape.
• Hospitals remain the largest end user of vagus nerve stimulator. FMI research indicates that specialty clinics and home care settings are emerging as attractive end user candidates in recent years.

Ready to Explore Our Methodology? Click Now!
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-7759

Thorough competition analysis of vagus nerve stimulator landscape reveals a few important developmental strategies that are ruling the minds of VNS manufacturers at present.

• Besides geographical expansion, leading players in vagus nerve stimulator market are focusing on the extension of their existing offerings portfolio, according to the report.
• In an effort to address the challenges to VNS adoption posed by the high price point, companies are now reassessing their pricing strategies for a competitive advantage.
• A number of companies are also directing their strategic focus on a stronger distribution network.
• Strategic partnerships with local and regional distributors and retailers hold immense importance for the competitors in VNS landscape.
• Long-term contractual collaborations with recognized hospitals, research and pathology laboratories, and CROs are emerging as a growing trend among manufacturers of vagus nerve stimulator.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:      

Nandini Singh Sawlani

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube